...
首页> 外文期刊>World Journal of Gastroenterology >Osteoclast-like giant cell tumors of the pancreas and liver.
【24h】

Osteoclast-like giant cell tumors of the pancreas and liver.

机译:胰腺和肝脏的破骨细胞样巨细胞瘤。

获取原文
获取原文并翻译 | 示例
           

摘要

Osteoclast-like giant cell tumors (OGCT) are rare abdominal tumors, which mainly occur in the pancreas. The neoplasms are composed of two distinct cell populations and frequently show an inhomogenous appearance with cystic structures. However, due to the rarity of these tumors, only very limited clinical data are available. Imaging features and sonographic appearance have hardly been characterized. Here we report on two cases of osteoclast-like giant cell tumors, one located within the pancreas, the other within the liver, in which OGCTs are extremely rare. Both patients were investigated by contrast sonography, which demonstrated a complex, partly cystic and strongly vascularized tumor within the head of the pancreas in the first patient and a large, hypervascularized neoplasm with calcifications within the liver in the second patient. The liver OGCT responded well to a combination of carboplatin, etoposide and paclitaxel. With a combination of surgical resection, radiofrequency ablation and chemotherapy, the patient's survival is currently more than 15 mo, making him the longest survivor with an OGCT of the liver to date.
机译:破骨细胞样巨细胞瘤(OGCT)是罕见的腹部肿瘤,主要发生在胰腺中。肿瘤由两个不同的细胞群组成,并经常显示出具有囊性结构的不均匀外观。然而,由于这些肿瘤的稀有性,仅可获得非常有限的临床数据。影像学特征和超声表现几乎没有特征。在这里,我们报道了两例破骨细胞样巨细胞瘤,其中一例位于胰腺内,另一例在肝脏内,其中OGCT非常罕见。两名患者均接受了超声造影检查,第一例患者的胰头内显示出复杂,部分囊性且血管强烈的肿瘤,第二例患者的肝脏内出现钙化的大血管化肿瘤。肝OGCT对卡铂,依托泊苷和紫杉醇的组合反应良好。结合手术切除,射频消融和化学疗法,患者的生存时间目前已超过15个月,这使他成为迄今为止肝OGCT最长的幸存者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号